Robert S. Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert S. Schwartz has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
Renu Virmani
CVPath Institute, Inc., Gaithersburg, Maryland
10 shared publicationsHidehiko Hara
Minneapolis Heart Institute and Foundation, 920 E 28th St, Minneapolis, MN 55407, USA
4 shared publicationsJohn R. Lesser
Minneapolis Heart Institute and Foundation at Abbott Northwestern Hospital, Minneapolis, MN
4 shared publicationsAndrew Carter
3 shared publicationsJudah Weinberger
3 shared publicationsKeith A. Robinson
3 shared publications
Latest Publications
- 1 October 2016
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 17 (7) , 470-473
Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation
- 1 October 2016
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 17 (7) , 470-473
Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation
- 18 November 2013
- Published by Elsevier in Revista Española de Cardiología Suplementos
- Vol. 13, 13-19
Modelos preclínicos de reestenosis: retos y éxitos
- 18 November 2013
- Published by Elsevier in Revista Española de Cardiología Suplementos
- Vol. 13, 13-19
Modelos preclínicos de reestenosis: retos y éxitos
- 22 April 2011
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 77 (6) , 828-829
On the trail to the holy grail
- 22 April 2011
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 77 (6) , 828-829
On the trail to the holy grail
- 1 August 2010
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 3 (8) , 870-877
Left Atrial Appendage Obliteration
- 1 August 2010
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 3 (8) , 870-877
Left Atrial Appendage Obliteration
- 23 April 2010
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 75 (6) , 977-978
Thrombus too big for pharmacology alone?
- 23 April 2010
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 75 (6) , 977-978
Thrombus too big for pharmacology alone?
- Open Access
- 1 October 2008
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 1 (2) , 143-153
Drug-Eluting Stents in Preclinical Studies
Coronary drug-eluting stents are commonplace in clinical practice with acceptable safety and efficacy. Preclinical evaluation of novel drug-eluting stent technologies has great importance for understanding safety and possibly efficacy of these technologies, and well-defined preclinical testing methods clearly benefit multiple communities within the developmental, testing, and clinical evaluation chain. An earlier consensus publication enjoyed widespread adoption but is in need of updating. This publication is an update, presenting an integrated view for testing drug-eluting technologies in preclinical models, including novel devices such as bioabsorbable coatings, totally bioabsorbable stents, bifurcation stents, and stent-free balloon-based drug delivery. This consensus document was produced by preclinical and translational scientists and investigators engaged in interventional technology community. The United States Food and Drug Administration (USFDA) recently issued a Draft Guidance for Industry Document for Drug-Eluting Stents. This expert consensus document is consistent with the Food and Drug Administration guidance. The dynamic nature of this field mandates future modifications and additions that will be added over time.
- 1 October 2008
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 1 (2) , 143-153
Open AccessDrug-Eluting Stents in Preclinical Studies
Coronary drug-eluting stents are commonplace in clinical practice with acceptable safety and efficacy. Preclinical evaluation of novel drug-eluting stent technologies has great importance for understanding safety and possibly efficacy of these technologies, and well-defined preclinical testing methods clearly benefit multiple communities within the developmental, testing, and clinical evaluation chain. An earlier consensus publication enjoyed widespread adoption but is in need of updating. This publication is an update, presenting an integrated view for testing drug-eluting technologies in preclinical models, including novel devices such as bioabsorbable coatings, totally bioabsorbable stents, bifurcation stents, and stent-free balloon-based drug delivery. This consensus document was produced by preclinical and translational scientists and investigators engaged in interventional technology community. The United States Food and Drug Administration (USFDA) recently issued a Draft Guidance for Industry Document for Drug-Eluting Stents. This expert consensus document is consistent with the Food and Drug Administration guidance. The dynamic nature of this field mandates future modifications and additions that will be added over time.
- 20 February 2008
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 71 (3) , 298
Epicardial pressure and flow: An important window on prognosis
- 20 February 2008
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 71 (3) , 298
Epicardial pressure and flow: An important window on prognosis
- 1 January 2008
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (1) , 35-39
Pregnancy-Associated Plasma Protein-A Elevation in Patients With Acute Coronary Syndrome and Subsequent Atorvastatin Therapy
- 1 January 2008
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (1) , 35-39
Pregnancy-Associated Plasma Protein-A Elevation in Patients With Acute Coronary Syndrome and Subsequent Atorvastatin Therapy
- 23 August 2007
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 70 (3) , 366-367
Ionizing radiation and the coronary arteries: The plot is thickening!
- 23 August 2007
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 70 (3) , 366-367
Ionizing radiation and the coronary arteries: The plot is thickening!